These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32216525)

  • 1.
    Womack KB; Dubiel R; Callender L; Dunklin C; Dahdah M; Harris TS; Devous MD; Juengst SB; Bell K; Diaz-Arrastia R; Ding K
    J Neurotrauma; 2020 Oct; 37(19):2113-2119. PubMed ID: 32216525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic abnormalities following traumatic brain injury.
    Jenkins PO; De Simoni S; Bourke NJ; Fleminger J; Scott G; Towey DJ; Svensson W; Khan S; Patel M; Greenwood R; Cole JH; Sharp DJ
    Brain; 2018 Mar; 141(3):797-810. PubMed ID: 29360949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stratifying drug treatment of cognitive impairments after traumatic brain injury using neuroimaging.
    Jenkins PO; De Simoni S; Bourke NJ; Fleminger J; Scott G; Towey DJ; Svensson W; Khan S; Patel MC; Greenwood R; Friedland D; Hampshire A; Cole JH; Sharp DJ
    Brain; 2019 Aug; 142(8):2367-2379. PubMed ID: 31199462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury.
    Wagner AK; Drewencki LL; Chen X; Santos FR; Khan AS; Harun R; Torres GE; Michael AC; Dixon CE
    J Neurochem; 2009 Feb; 108(4):986-97. PubMed ID: 19077052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new quantitative index in the diagnosis of Parkinson syndrome by dopamine transporter single-photon emission computed tomography.
    Bando R; Otsuka H; Otani T; Matsuda N; Azane S; Kunikane Y; Otomi Y; Sako W; Izumi Y; Harada M
    Ann Nucl Med; 2021 Apr; 35(4):504-513. PubMed ID: 33630226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson's disease.
    Jenkins PO; Roussakis AA; De Simoni S; Bourke N; Fleminger J; Cole J; Piccini P; Sharp D
    J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):631-637. PubMed ID: 32381639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPECT study using 123I-beta-CIT and 123I-IBZM.
    Donnemiller E; Brenneis C; Wissel J; Scherfler C; Poewe W; Riccabona G; Wenning GK
    Eur J Nucl Med; 2000 Sep; 27(9):1410-4. PubMed ID: 11007526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine transporter density in the basal ganglia in obsessive-compulsive disorder, measured with [123I]IPT SPECT before and after treatment with serotonin reuptake inhibitors.
    Kim CH; Cheon KA; Koo MS; Ryu YH; Lee JD; Chang JW; Lee HS
    Neuropsychobiology; 2007; 55(3-4):156-62. PubMed ID: 17657168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study.
    Sossi V; de la Fuente-Fernández R; Schulzer M; Troiano AR; Ruth TJ; Stoessl AJ
    Ann Neurol; 2007 Nov; 62(5):468-74. PubMed ID: 17886297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys.
    Fischman AJ; Babich JW; Elmaleh DR; Barrow SA; Meltzer P; Hanson RN; Madras BK
    J Nucl Med; 1997 Jan; 38(1):144-50. PubMed ID: 8998169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological challenge and synaptic response - assessing dopaminergic function in the rat striatum with small animal single-photon emission computed tomography (SPECT) and positron emission tomography (PET).
    Nikolaus S; Larisch R; Vosberg H; Beu M; Wirrwar A; Antke C; Kley K; Silva MA; Huston JP; Müller HW
    Rev Neurosci; 2011; 22(6):625-45. PubMed ID: 22103308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical comparison of 99mTc exametazime and 123I Ioflupane SPECT in patients with chronic mild traumatic brain injury.
    Newberg AB; Serruya M; Gepty A; Intenzo C; Lewis T; Amen D; Russell DS; Wintering N
    PLoS One; 2014; 9(1):e87009. PubMed ID: 24475210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau accumulation is associated with dopamine deficiency in vivo in four-repeat tauopathies.
    Ferschmann C; Messerschmidt K; Gnörich J; Barthel H; Marek K; Palleis C; Katzdobler S; Stockbauer A; Fietzek U; Finze A; Biechele G; Rumpf JJ; Saur D; Schroeter ML; Rullmann M; Beyer L; Eckenweber F; Wall S; Schildan A; Patt M; Stephens A; Classen J; Bartenstein P; Seibyl J; Franzmeier N; Levin J; Höglinger GU; Sabri O; Brendel M; Scheifele M;
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1909-1922. PubMed ID: 38366196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep.
    Michaud M; Soucy JP; Chabli A; Lavigne G; Montplaisir J
    J Neurol; 2002 Feb; 249(2):164-70. PubMed ID: 11985381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Franceschi D; Maynard L; Ding YS; Gatley SJ; Gifford A; Zhu W; Swanson JM
    Synapse; 2002 Mar; 43(3):181-7. PubMed ID: 11793423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation.
    Greco A; Zannetti A; Pappatà S; Albanese S; Coda AR; Ragucci M; Nardelli A; Brunetti A; Cuocolo A; Salvatore M
    Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):112-117. PubMed ID: 26329495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [[(123)I]-Ioflupane SPECT in combination with MIBG myocardial scintigraphy in Parkinson's disease: a case series study].
    Yamada A; Murakami T; Kang Y; Iikuni Y; Morimatsu A; Shirata A; Ito H; Ugawa Y; Yamane K
    Rinsho Shinkeigaku; 2016 Jun; 56(6):400-6. PubMed ID: 27212677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.
    Booij J; Tissingh G; Boer GJ; Speelman JD; Stoof JC; Janssen AG; Wolters EC; van Royen EA
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):133-40. PubMed ID: 9048712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of endogenous dopamine release by methylphenidate challenge using iodine-123 iodobenzamide single-photon emission tomography.
    Booij J; Korn P; Linszen DH; van Royen EA
    Eur J Nucl Med; 1997 Jun; 24(6):674-7. PubMed ID: 9169577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative [123]I-Ioflupane DaTSCAN single-photon computed tomography-computed tomography in Parkinsonism.
    Missir E; Begley P; Jessop M; Singh N; Aplin M; McMeekin H; Parekh P; Raczek M; Dizdarevic S
    Nucl Med Commun; 2023 Oct; 44(10):843-853. PubMed ID: 37395542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.